Share your thoughts on this presentation with #IAS2019

Slides:



Advertisements
Similar presentations
Vertical versus Decentralized TB Pharmaceutical Management
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
The Roadmap to Successful Xpert Implementation - 37 steps -
The 2013 Consolidated WHO Guidelines on ARV Use: Implementing to Achieve Maximum Impact Gottfried Hirnschall, MD, MPH Director, HIV/AIDS Department, WHO.
The Future of HIV Diagnostics: Market Trends for CD4 and VL Testing Decade of Diagnostics Satellite Kuala Lumpur July 2, 2013.
World Health Organization
The Future of Purchasing in Victorian Health Steve Sant Health Purchasing Victoria.
Pharmaceuticals Procurement and Supply Management: The case of Ethiopia Cambodia, December 4,
Stable Outcomes and Costs in South African Patients’ Second Year on Antiretroviral Treatment Lawrence Long, Health Economics Research Office, Wits Health.
Procurement Support Services WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, October 29 th - November 2 nd 2012 Mariatou Tala Jallow.
Application of an International Reference Price List to National Medicines Procurement Tenders Bada Pharasi, Gavin Steel, Jean-Pierre Sallet, SPS, Management.
Global Fund – PEPFAR Coordination The Tanzania Example Dr. Fatma Mrisho Chairperson TACAIDS.
Measles Partnership Meeting Yalda Momeni September 23 rd - WDC.
PROCUREMENT SUPPORT SERVICE WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November 1 st -5 th 2010 Mariatou Tala Jallow, Manager,
MINISTRY OF PUBLIC HEALTH AND SOCIAL WELFARE EL SALVADOR, CENTRAL AMERICA EXPERIENCE WITH CONTRACEPTIVE PROCUREMENT Ministry of Health, El Salvador OCTOBER.
ADVANCING ONE FLORIDA IN THE AGE OF STRATEGIC SOURCING Windell Paige, Director, Office of Supplier Diversity (OSD) Russ Rothman, CPPO, FCPM, Chief Purchasing.
Integrated Supply Chain Management in Public Health The All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases 16 October, 2012; Portcullis.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Good Procurement Practices in National TB Programs
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
The Rising Prevalence of NCDs: Implications for Health Financing and Policy Charles Holmes, MD, MPH Office of the U.S. Global AIDS Coordinator Department.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Lucile de Comarmond Chief Pharmacist Workshop on Impact of TRIPS/IP on Access to Medicine September 2014.
Price Considerations for TB Drugs. Goals of Effective Procurement Selecting appropriate medicines Meeting required quality standards In right quantities.
Experience with common basket for ARV procurement Tanzania Emma Lekashingo Msuya.
Overview of the Global Fund Procurement and Supply Management Issues Workshop for LAC Consultants th July 2009 Pharmaceutical Management Advisory.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
1 Introduction to the Clinton Foundation HIV/AIDS Initiative 12 July 2007 Africa Recruit.
Improving Access to Essential Medicines through Public-Private Initiatives: The Case of the Catholic Pharmaceutical Service in Ghana.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
Regional procurement policies and access to medicines - lessons from the SADC Pooled Procurement project Wilbert Bannenberg SARPAM.
IMPROVING ACCESS AND INNOVATION IN HIV THROUGH VOLUNTARY LICENSING: THE EXPERIENCE OF THE MEDICINES PATENT POOL ICASA – Harare, Zimbabwe Session on Innovation.
Optimizing the Cost and Quality of HIV / AIDS Care and Treatment Anil Soni, Clinton HIV / AIDS Initiative 19 th Board Meeting, Geneva 6 May 2009.
UNITAID actions and main achievements Investing in the quality of medicines XVII International AIDS Conference Satellite Forum WHO – Essential Medicines.
Rapid scale up of Pharmacy module use at Mtwara region in strengthening Antiretroviral commodity management Yefta Emmanuel THPS - Pharmacy Technical Advisor.
TOWARDS PUBLIC PROCUREMENT KEY PERFORMANCE INDICATORS Paulo Magina Head of the Public Procurement Unit Public Sector Integrity Division 10 th INGP Annual.
Work shop on Procurement Key-performance indicators with selected implementing entities Public procurement and property administration agency August 2016.
Purchasing Suppliers.
How differentiated care supports “Tx all” and Dr
Costing Health and HIV services in Kenya
Discussion and Conclusion
HIV and AIDS The management of HIV and AIDS is an ongoing challenge for Anglo companies operating in countries with a high burden of HIV disease Strategy.
Characterizing the South Africa ART Market
STRATEGIC SOURCING SUMMARY
Pharmacoeconomics of generics
12.2 Conduct Procurements The process of obtaining seller responses, selecting a seller and awarding the contract The team applies selection criteria.
Community pharmacy in 2016/17 and beyond – final package
Utilizing research as an opportunity to strengthen
The Lean Sourcing Process
International AIDS Economics Network (IAEN) Conference
South African HIV Care Cascades Data Sources
Outline Session 7:00 FRSA0701 Welcome and introductions : WHO general approach to cascade analysis framework : From Cascade Analysis to Action  Jesus M.
Role of Contracting and Procurement Services in WHO
Access to HIV/AIDS Medicines The 3x5 strategy
Fatima Oliveira Tsiouris Deputy Director, Clinical & Training Unit
July 21, 2016 Potential Domestic Source Financing for Scaled Up Antiretroviral Therapy in 97 Countries, 2016–2020 Arin Dutta, Catherine Barker, and Ashley.
USAID STRENGTHENING THE CARE CONTINUUM PROJECT (The Care Continuum)
Towards the last 90% of the 90:90:90 strategy: A review of viral suppression rates in a HIV program in Central and Eastern Kenya Dr Moses Kitheka,
How it was possible to offer Integrase Inhibitor as first line ART while maintaining the sustainability of the Brazilian policy of universal access to.
Financing South Africa’s HIV Response
Demand Forecasts for for HIV/AIDS ARV formulations
Goal 6: Combat HIV/AIDS, malaria and other diseases
TRANSITION TO TLD – ZIMBABWE REPORT
The meeting of INTOSAI Working GROUP on Public Procurement Audit July 4-5 Lisbon Abstract of State Audit Bureau of Kuwait in conducting the public procurement.
The Case of the Catholic Pharmaceutical Service in Ghana
Silvia Bertagnolio, MD HIV Department World Health Organization
Multi-disease diagnostic integration
Target-Setting, Impact and Resource Needs
Update on global progress in ART
Introduction and current status of viral load access
Presentation transcript:

Share your thoughts on this presentation with #IAS2019 Achieving Low Antiretroviral (ARV) Costs through Competitive National Tendering and Strategic Reference Pricing: Results from the Republic of South Africa’s Recently Awarded ARV Tender (RT71-2019) Herbert Musariri (on behalf of Republic of South Africa National Department of Health) Share your thoughts on this presentation with #IAS2019

Background of South Africa’s Treatment Program People living with HIV (PLHIV) 4.7M On antiretroviral treatment (ART) 4.1M Virally suppressed (VL <1,000 copies/mL) 62% 88% South Africa represents the largest HIV treatment program in the world Sources: Thembisa Model Version 4.2 : https://www.thembisa.org/,accessed July 2019; District Health Information System (DHIS): https://za.dhis.dhmis.org, accessed July 2019; figures are for May 2019; National Health Laboratory Services (NHLS)

National Timeline Preparing for ARV Tender (RT71-2019) Key National Tender Milestones Forecasting and Quantification (May – July 2018) Tender Advertised (August 2018) Reference Price List Special Conditions of Contract explicitly indicate that submitted prices must not exceed reference prices Price Negotiations The State reserves the right to negotiate with the bidders prior to award and with the successful bidder(s) post award Tender Award Announced (Feb 2019)

Key Highlights from RT71-2019 Tender Award: TLD Supplier TLD Delivery Price (ZAR) TLD Quantity Awarded (pack in millions, rounded) Macleods R 75.13 20.0M Mylan R 78.78 18.8M Hetero R 83.70 17.8M Cipla R 86.50 20.3M Aurobindo R 87.28 16.9M Sonke R 89.68 18.9M Pharmacare R 95.21 17.5M Adcock Ingram R 98.61 16.8M R 87 Weighted average delivery price per pack for TLD awarded in RT71-2019 147M Estimated quantity required (in packs) of TLD during the 3 year tender period 8 Suppliers awarded TLD volumes (with 3 being local), promoting supply security

Utilizing Reference Pricing To Achieve Cost Savings At the 2017 United Nations General Assembly, the governments of South Africa and Kenya together with many partners, including CHAI, BMGF, and Unitaid, announced a new pricing agreement for TLD with Aurobindo and Mylan TLD Pricing Agreement September 2017 US$75 Average cost per patient per year for generic TLD The global reference pricing for TLD helped inform the advertised ceiling prices. In the end, through its large volumes, South Africa was able to achieve a significant price reduction from the global benchmark pricing agreement for TLD -13% Notes: *Prices shown reflect EXW (i.e., no freight); RSA’s prices estimated by removing 15% VAT and ~7% mark-up for delivery (DDP); Assumed SA Rand to USD RoE of 14.20; given 28 pack size for nearly all award volumes, assuming 13 packs needed for year-long treatment; PPPY = per patient per year

South Africa’s Cost for Preferred Adult 1st-Line (1L) ARV Regimens Has Decreased Significantly Over Time Annual Delivery Cost for Highest Volume Adult 1L Regimens Per Awarded Tender Price reductions could result in  ARV procurement cost savings of roughly 43% corresponding to R4.6 Billion ($326 Million) over the 3 year tender cycle.   Savings estimated as the difference in total value of the current and immediate past tender based on items awarded in both tenders. Notes: Cost calculations based on delivery prices which include 15% VAT and ~7% mark-up for delivery (DDP) ); Assumed SA Rand to USD RoE at time of tender award; given 28 pack size for nearly all award volumes, assuming 13 packs needed for year-long treatment. Pack sizes were 30-day prior to 2013.

Adult 1L ART Program: Patient Estimates and Cost South Africa’s Ability to Decrease Cost of Treatment Has Enabled the Country to Minimize Cost of Scaling-Up Treatment for All Adult 1L ART Program: Patient Estimates and Cost The steady decrease in cost has allowed South Africa to quadruple the number of adult 1st line patients since 2011, with a marginal impact on ARV drug budget. = Notes:

TLD Rollout & Implementation Plan Guidelines Finalized: May 2019 Training: July-September 2019 TLD Introduction: September 2019 Monitoring TLD uptake: Ongoing

Lessons Learnt from Tendering and Award RT71-2019 Widening the pool of potential suppliers, ensures a competitive tender process, which thereby ensures best prices and facilitates supply security Global cooperation is key for setting benchmark prices for countries to leverage. Utilizing global reference prices and establishing ceiling prices in tendering advertisements can help drive down costs Public posting of awarded prices and volumes is helpful in enabling other countries to reference during their own tendering negotiations